Hebei Changshan Biochemical Pharmaceutical (300255.SZ)'s controlling shareholder Gao Shuhua intends to transfer 46 million shares of the company through an agreement.
Changshan Pharmaceutical (300255.SZ) announcement, the company's controlling shareholder and actual controller Mr. Gaoshuhua intends to transfer through agreement...
Hebei Changshan Biochemical Pharmaceutical (300255.SZ) announced that the controlling shareholder and actual controller, Mr. Gao Shuhua, intends to transfer 46 million shares of the company's unrestricted tradable shares (accounting for 5.0051% of the total share capital of the company) to Chongqing Element Private Equity Securities Investment Fund Management Co. Ltd. (representing "Element Zhiyuanxing Qianli Yihao Private Equity Securities Investment Fund," or "Element Fund") through an agreement transfer at a price of 46.25 yuan per share. After the completion of the agreement transfer, Element Fund will hold 46 million shares of the company, accounting for 5.0051% of the current total share capital of the company, and will become a shareholder with more than 5% of the company.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


